Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endocalyx for Vascular Function in Type 2 Diabetes
NCT05205005Phase 3Completed
- Sponsor
- VA Office of Research & Development
- Start
- May 2022
- Primary completion
- Mar 2024
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial (2 arms), sponsored by VA Office of Research & Development. Primary endpoint: Glycocalyx Integrity - Perfused Boundary Region at 8 weeks. Started May 2022; status: completed.
Beyond the preview
Go deeper on NCT05205005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05205005.